These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 8527687)

  • 1. Bioavailability of pseudoephedrine from controlled release formulations in the presence of guaifenesin in human volunteers.
    Pade V; Aluri J; Manning L; Stavchansky S
    Biopharm Drug Dispos; 1995 Jul; 16(5):381-91. PubMed ID: 8527687
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bioavailability of dextromethorphan (as dextrorphan) from sustained release formulations in the presence of guaifenesin in human volunteers.
    Demirbas S; Reyderman L; Stavchansky S
    Biopharm Drug Dispos; 1998 Nov; 19(8):541-5. PubMed ID: 9840216
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of food on the oral bioavailability of loratadine and pseudoephedrine from extended-release tablets in healthy volunteers.
    Nomeir AA; Mojaverian P; Kosoglou T; Affrime MB; Nezamis J; Rodwanski E; Lin CC; Cayen MN
    J Clin Pharmacol; 1996 Oct; 36(10):923-30. PubMed ID: 8930779
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro and in vivo evaluation of a once-daily controlled-release pseudoephedrine product.
    Hwang SS; Gorsline J; Louie J; Dye D; Guinta D; Hamel L
    J Clin Pharmacol; 1995 Mar; 35(3):259-67. PubMed ID: 7608314
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Time-controlled release pseudoephedrine tablets: bioavailability and in vitro/in vivo correlations.
    Halsas M; Penttinen T; Veski P; Jürjenson H; Marvola M
    Pharmazie; 2001 Sep; 56(9):718-23. PubMed ID: 11593992
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics of loratadine and pseudoephedrine following single and multiple doses of once- versus twice-daily combination tablet formulations in healthy adult males.
    Kosoglou T; Radwanski E; Batra VK; Lim JM; Christopher D; Affrime MB
    Clin Ther; 1997; 19(5):1002-12. PubMed ID: 9385487
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics of methylphenidate after oral administration of two modified-release formulations in healthy adults.
    Markowitz JS; Straughn AB; Patrick KS; DeVane CL; Pestreich L; Lee J; Wang Y; Muniz R
    Clin Pharmacokinet; 2003; 42(4):393-401. PubMed ID: 12648029
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bioavailability of pseudoephedrine and triprolidine from combination and single-ingredient products.
    Williams BO; Liao SH; Lai AA; Arnold JD; Perkins JG; Blum MR; Findlay JW
    Clin Pharm; 1984; 3(6):638-43. PubMed ID: 6509877
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of a standard meal on the absorption of controlled-release pseudoephedrine capsules.
    Wecker MT; Graves DA; Amsel LP; Hinsvark ON; Rotenberg KS
    J Pharm Sci; 1987 Jan; 76(1):29-31. PubMed ID: 3585719
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bioavailability assessment of a new liquid controlled-release pseudoephedrine product.
    Graves DA; Rotenberg KS; Woodworth JR; Amsel LP; Hinsvark ON
    Clin Pharm; 1985; 4(2):199-203. PubMed ID: 3987221
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential pharmacokinetics of diclofenac potassium for oral solution vs immediate-release tablets from a randomized trial: effect of fed and fasting conditions.
    Chen C; Bujanover S; Kareht S; Rapoport AM
    Headache; 2015 Feb; 55(2):265-75. PubMed ID: 25546369
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relative bioavailability and bioequivalence of a newly developed fixed combination sachet of acetylsalicylic acid and pseudoephedrine compared with a preliminary combination.
    Lücker PW; Birkel M; Hey B; Loose I; Schaefer A
    Methods Find Exp Clin Pharmacol; 2003 Oct; 25(8):631-7. PubMed ID: 14671681
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vivo performance of controlled release pellets of diltiazem HCl.
    Nisarur-ur-Rahman ; K H Y; Jia Woei W
    Pak J Pharm Sci; 2005 Apr; 18(2):44-8. PubMed ID: 16431398
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In-vivo/in-vitro correlation of four extended release formulations of pseudoephedrine sulfate.
    Mojaverian P; Rosen J; Vadino WA; Liebowitz S; Radwanski E
    J Pharm Biomed Anal; 1997 Jan; 15(4):439-45. PubMed ID: 8953486
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro dissolution and in vivo oral absorption of methylphenidate from a bimodal release formulation in healthy volunteers.
    Wang Y; Lee L; Somma R; Thompson G; Bakhtiar R; Lee J; Rekhi GS; Lau H; Sedek G; Hossain M
    Biopharm Drug Dispos; 2004 Mar; 25(2):91-8. PubMed ID: 14872557
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Single-dose and steady-state bioequivalence of fexofenadine and pseudoephedrine combination tablets compared with individual formulations in healthy adults.
    Howard DR; Haribhakti R; Kittner B; Agrawala P
    Curr Med Res Opin; 2005 May; 21(5):769-76. PubMed ID: 15969876
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Determination of guaifenesin in human plasma by liquid chromatography in the presence of pseudoephedrine.
    Aluri JB; Stavchansky S
    J Pharm Biomed Anal; 1993 Sep; 11(9):803-8. PubMed ID: 8218524
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative bioavailability study of doxycycline hyclate (equivalent to 100 mg doxycycline) capsules (doxycin vs vibramycin) for bioequivalence evaluation in healthy adult volunteers.
    Alsarra IA; Al-Said MS; Al-Khamis KI; Niazy EM; El-Sayed YM; Al-Rashood KA; Al-Yamani MJ; Al-Balla SA
    Int J Clin Pharmacol Ther; 2004 Jul; 42(7):373-7. PubMed ID: 15605689
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of sustained-action chlorpheniramine-pseudoephedrine dosage form in humans.
    Yacobi A; Stoll RG; Chao GC; Carter JE; Baaske DM; Kamath BL; Amann AH; Lai CM
    J Pharm Sci; 1980 Sep; 69(9):1077-81. PubMed ID: 7411413
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetics of guaifenesin, pseudoephedrine and hydrocodone in a combination oral liquid formulation, administered as single and multiple doses in healthy Chinese volunteers, and comparison with data for individual compounds formulated as Antuss®.
    Deng S; Huang W; Ni X; Zhang M; Lu H; Wang Z; Hu J; Zhu X; Qiu C; Shang D; Zhang Y; Xiong L; Wen Y
    Xenobiotica; 2017 Oct; 47(10):870-878. PubMed ID: 27662264
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.